Skip to content

Enteral nutrition and gastric ulcer in critically ill patients

Comparing efficacy and safety of enteral nutrition with and without ranitidine in prevention of gastric ulcer in critically ill patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201604213449N21
Enrollment
50
Registered
2016-05-30
Start date
2016-05-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Ulcer. Stress Induced Gastric Ulcer

Interventions

Intervention 1: Intervention group: Enteral feeding as 50 ml at beginning and then increasing 50 ml every 3 hours up to 200 ml every 3 hours. Intervention 2: Control group: Enteral feeding (same as th
Prevention
Intervention group: Enteral feeding as 50 ml at beginning and then increasing 50 ml every 3 hours up to 200 ml every 3 hours.
Control group: Enteral feeding (same as the intervention group) plus ranitidine amp, 50 mg every 8 hours as slow intravenous injection for 7 days.

Sponsors

Vice Chancellor for Research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Critically ill adult patients with indication of gastric ulcer prophylaxis without contraindication for enteral nutrition will be recruited. Exclusion criteria: Patients with history of active gastric ulcer in month before inclusion; gastric bleeding in time of hospitalization; coagulopathy; enteral feeding intolerance; severe burn; head trauma; increased intracranial pressure

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Stress induced gastric ulcer. Timepoint: At baseline and daily for 7 days. Method of measurement: Evaluation of gastrointestinal symptoms including gastric intolerance, coffe ground secretions from tube feeding, melena and hematemesis.

Secondary

MeasureTime frame
Complications of gastric acid suppressant agents. Timepoint: At baseline and daily for 7 days. Method of measurement: Evaluation of patients for pneumonia and diarrehea.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Khalili

Tehran University of Medical Sciences

khalilih@tums.ac.ir+98 21 6119 2112

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026